Company Overview of SanBio, Inc.
SanBio, Inc. develops regenerative therapies for neurological disorders. Its product pipeline includes SB623 that reverses neural damages, as well as restores functions to damaged neurons associated with strokes, traumatic brain injuries, retinal diseases, and Parkinson's diseases; and SB618 for the treatment of neuron inflammatory injury conditions (multiple sclerosis and spinal cord injuries). The company was founded in 2001 and is based in Mountain View, California. SanBio, Inc. operates as a subsidiary of SanBio Company Limited.
231 South Whisman Road
Mountain View, CA 94041-1522
Founded in 2001
Key Executives for SanBio, Inc.
SanBio, Inc. Key Developments
Similar Private Companies By Industry
|1st Order Pharmaceuticals, Inc.||United States|
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact SanBio, Inc., please visit www.san-bio.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.